Ven Bio Partners LLC Pharvaris N.V. Transaction History
Ven Bio Partners LLC
- $122 Million
- Q3 2024
A detailed history of Ven Bio Partners LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Ven Bio Partners LLC holds 4,289,304 shares of PHVS stock, worth $79.4 Million. This represents 65.3% of its overall portfolio holdings.
Number of Shares
4,289,304
Previous 4,289,304
-0.0%
Holding current value
$79.4 Million
Previous $80.6 Million
1.49%
% of portfolio
65.3%
Previous 45.57%
Shares
7 transactions
Others Institutions Holding PHVS
# of Institutions
51Shares Held
39.6MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$139 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$81.4 Million53.23% of portfolio
-
Viking Global Investors LP3.65MShares$67.6 Million0.26% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$62.8 Million6.51% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$61.1 Million10.98% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $625M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...